Clinical trial
GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus…
NCT00123578 · University of California, Los Angeles, Other · Withdrawn
Key facts
| NCT number | NCT00123578 |
|---|---|
| Title | GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 |
| Official title | GHB: Effects, Withdrawal and Treatment |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Lorazepam, Pentobarbital |
| Enrollment | 0 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 25, 2005 |
| Last update posted | May 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: